ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Funding Opportunities

December 6, 2002

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade

February 22, 2013

June Panel Meeting Dropped

June 3, 1977

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985